48
Views
0
CrossRef citations to date
0
Altmetric
Review

Miller Fisher syndrome is a nodo-paranodopathy, but not a myelinopathy

&
Pages 15-24 | Published online: 07 Jan 2015

References

  • Fisher M . An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med.255(2), 57–65 (1956).
  • Chiba A , KusunokiS, ShimizuT, KanazawaI. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol.31(6), 677–679 (1992).
  • Chiba A , KusunokiS, ObataH, MachinamiR, KanazawaI. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain–Barré syndrome: clinical and immunohistochemical studies. Neurology43(10), 1911–1917 (1993).
  • Kusunoki S , ChibaA, KanazawaI. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve22(8), 1071–1074 (1999).
  • Yuki N , SusukiK, HirataK. Ataxic Guillain–Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology54(9), 1851–1853 (2000).
  • Ogawara K , KuwabaraS, YukiN. Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems. Muscle Nerve26(6), 845–849 (2002).
  • Yuki N . Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann. Neurol.39(5), 668–672 (1996).
  • Guiloff RJ . Peripheral nerve conduction in Miller Fisher syndrome. J. Neurol. Neurosurg. Psychiatry40(8), 801–807 (1977).
  • Jamal GA , MacLeodWN. Electrophysiologic studies in Miller Fisher syndrome. Neurology34(5), 685–688 (1984).
  • Fross RD , DaubeJR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology37(9), 1493–1498 (1987).
  • Katsuno M , AndoT, HakusuiS, YanagiT, SobueG. Motor conduction studies in Miller Fisher syndrome with severe tetraparesis. Muscle Nerve25(3), 378–382 (2002).
  • Kuwabara S , OgawaraK, MizobuchiKet al. Isolated absence of F waves and proximal axonal dysfunction in Guillain–Barré syndrome with antiganglioside antibodies. J. Neurol. Neurosurg. Psychiatry68(2), 191–195 (2000).
  • Funakoshi K , KuwabaraS, OdakaM, HirataK, YukiN. Clinical predictors of mechanical ventilation in Fisher/Guillain–Barré overlap syndrome. J. Neurol. Neurosurg. Psychiatry80(1), 60–64 (2009).
  • Sauron B , BoucheP, CathalaHP, ChainF, CastaigneP. Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology34(7), 953–956 (1984).
  • Lyu RK , ChangKH, ChuCC, KuoHC, RoLS. Sensory conduction study in Fisher syndrome: patterns of abnormalities and their clinical correlation. Eur. Neurol.70(1–2), 27–32 (2013).
  • Shahrizaila N , GohKJ, KokubunN, TanAH, TanCY, YukiN. Sensory nerves are frequently involved in the spectrum of Fisher Syndrome. Muscle Nerve49(4), 558–563 (2014).
  • Shimamura H , MiuraH, IwakiYet al. Clinical, electrophysiological, and serological overlap between Miller Fisher syndrome and acute sensory ataxic neuropathy. Acta Neurol. Scand.105(5), 411–413 (2002).
  • Ito M , KuwabaraS, OdakaMet al. Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J. Neurol.255(5), 674–682 (2008).
  • Dachy B , DeltenreP, DeconinckN, DanB. The H reflex as a diagnostic tool for Miller Fisher syndrome in pediatric patients. J. Clin. Neurosci.17(3), 410–411 (2010).
  • Sekiguchi Y , MisawaS, ShibuyaKet al. Patterns of sensory nerve conduction abnormalities in Fisher syndrome: more predominant involvement of group Ia afferents than skin afferents. Clin. Neurophysiol.124(7), 1465–1469 (2013).
  • Weiss JA , WhiteJC. Correlation of 1a afferent conduction with the ataxia of Fisher syndrome. Muscle Nerve9, 327–332 (1986).
  • Kuwabara S , AsahinaM, NakajimaMet al. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann. Neurol.45(4), 533–536 (1999).
  • Kuwabara S , YukiN, KogaMet al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain–Barré syndrome. Ann. Neurol.44(2), 202–208 (1998).
  • Kokubun N , NishibayashiM, UnciniA, OdakaM, HirataK, YukiN. Conduction block in acute motor axonal neuropathy. Brain133(10), 2897–2908 (2010).
  • Susuki K , YukiN, SchaferDPet al. Dysfunction of nodes of Ranvier: a mechanism for antiganglioside antibody-mediated neuropathies. Exp. Neurol.233(1), 534–542 (2012).
  • Uncini A , LugaresiA. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve22(5), 640–644 (1999).
  • Umapathi T , TanEY, KokubunN, VermaK, YukiN. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J. Neurol. Neurosurg. Psychiatry83(9), 941–948 (2012).
  • Capasso M , NotturnoF, ManzoliC, UnciniA. Involvement of sensory fibres in axonal subtypes of Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatry82(6), 664–670 (2011).
  • Yuki N , ShahrizailaN. Keeping it simple: is there a need for the various subtyping of axonal forms of Guillain-Barre syndrome?J. Neurol. Neurosurg. Psychiatry82(6), 592 (2011).
  • Chan YC , AhmadA, PaliwalP, YukiN. Non-demyelinating, reversible conduction failure in a case of pharyngeal-cervical-brachial weakness overlapped by Fisher syndrome. J. Neurol. Sci.321(1–2), 103–106 (2012).
  • Gürsoy AE , KolukısaM, Babacan-YıldızG, AltıntaşÖ, YamanA, AsilT. Reversible conduction failure in overlap of Miller Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain–Barré syndrome in the spectrum of nodo-paranodopathies. J. Clin. Neurosci.21(7), 1269–1271 (2014).
  • Uncini A , SusukiK, YukiN. Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin. Neurophysiol.124(10), 1928–1934 (2013).
  • Umapathi T , LimCS, YukiN. Serial nerve conduction studies show changes in the axonal excitability of motor and sensory nerves in Fisher syndrome. J. Peripher. Nerv. Syst.18(3), 266–268 (2013).
  • Uncini A , ManzoliC, NotturnoF, CapassoM. Pitfalls in electrodiagnosis of Guillain–Barré syndrome subtypes. J. Neurol. Neurosurg. Psychiatry81(10), 1157–1163 (2010).
  • Shahrizaila N , GohKJ, KokubunN, AbdullahS, YukiN. Serial nerve conduction studies provide insight into the pathophysiology of Guillain–Barré and Fisher syndromes. J. Neurol. Sci.309(1–2), 26–30 (2011).
  • Rajabally YA , Hassan-SmithG, NotturnoFet al. Motor and sensory conduction failure in overlap of Guillain–Barré and Miller Fisher syndrome: two simultaneous cases. J. Neurol. Sci.303(1–2), 35–38 (2011).
  • Kimura J . Electrodiagnosis in disease of nerve and muscle. Principles and practice (4th Edition).Oxford University Press, NY, USA (2013).
  • Yu RK , TsaiYK, ArigaT, YanagisawaM. Structures, biosynthesis, and functions of gangliosides‐‐an overview. J. Oleo. Sci.60(10), 537–544 (2011).
  • Liu JX , WillisonHJ, Pedrosa-DomellöfF. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest. Ophthalmol. Vis. Sci.50(7), 3226–3232 (2009).
  • Yuki N , YoshinoH, SatoS, MiyatakeT. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology40(12), 1900–1902 (1990).
  • Susuki K , RasbandMN, TohyamaKet al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci.27(11), 3956–3967 (2007).
  • Griffin JW , LiCY, MackoCet al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain–Barré syndrome. J. Neurocytol.25(1), 33–51 (1996).
  • Hafer-Macko C , HsiehST, LiCYet al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol.40(4), 635–644 (1996).
  • Ogawara K , KuwabaraS, MoriM, HattoriT, KogaM, YukiN. Axonal Guillain–Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol.48(4), 624–631 (2000).
  • Koga M , TakahashiM, MasudaM, HirataK, YukiN. Campylobacter gene polymorphism as a determinant of clinical features of Guillain–Barré syndrome. Neurology65(9), 1376–1381 (2005).
  • Yuki N , TakiT, InagakiFet al. A bacterium lipopolysaccharide that elicits Guillain–Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med.178(5), 1771–1775 (1993).
  • Koga M , GilbertM, TakahashiMet al. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis. J. Infect. Dis.193(4), 547–555 (2006).
  • Gilbert M , BrissonJR, KarwaskiMFet al. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-MHz 1H and 13C NMR analysis. J. Biol. Chem.275(6), 3896–3906 (2000).
  • Kimoto K , KogaM, OdakaMet al. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology67(10), 1837–1843 (2006).
  • Yuki N , HartungHP. Guillain–Barré syndrome. N. Engl. J. Med.366(24), 2294–2304 (2012).
  • Willison HJ , GoodyearCS. Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends Immunol.34(9), 453–459 (2013).
  • Kaida K , MoritaD, KanzakiMet al. Ganglioside complexes as new target antigens in Guillain–Barré syndrome. Ann. Neurol.56(4), 567–571 (2004).
  • Kaida K , KanzakiM, MoritaDet al. Anti-ganglioside complex antibodies in Miller Fisher syndrome. J. Neurol. Neurosurg. Psychiatry77(9), 1043–1046 (2006).
  • Koga M , GilbertM, TakahashiMet al. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J. Neurol.259(7), 1366–1374 (2012).
  • Kanzaki M , KaidaK, UedaMet al. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain–Barré syndromes. J. Neurol. Neurosurg. Psychiatry79(10), 1148–1152 (2008).
  • Yuki N , SusukiK, HirataK. Ataxic form of Guillain–Barré syndrome associated with anti-GD1b IgG antibody. J. Neurol. Neurosurg. Psychiatry69(1), 136–137 (2000).
  • Notturno F , CaporaleCM, UnciniA. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery. Muscle Nerve37(2), 265–268 (2008).
  • Ito M , MatsunoK, SakumotoY, HirataK, YukiN. Ataxic Guillain–Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J. Neurol. Neurosurg. Psychiatry82(3), 294–299 (2011).
  • Susuki K , YukiN, HirataK. Fine specificity of anti-GQ1b IgG and clinical features. J. Neuro. Sci.185(1), 5–9 (2001).
  • Yuki N , FukamiY, YanakaC, KoikeS, HirataK. GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia. J. Neurol.261(8), 1565–1569 (2014).
  • Chiba A , KusunokiS, ObataH, MachinamiR, KanazawaI. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res.745(1–2), 32–36 (1997).
  • Lopez PH , ZhangG, ZhangJet al. Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair. J. Neurosci.30(28), 9533–9541 (2010).
  • Koga M , YoshinoH, MorimatsuM, YukiN. Anti-GT1a IgG in Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatry72(6), 767–771 (2002).
  • Kornberg AJ , PestronkA, BlumeGM, LopateG, YueJ, HahnA. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology47(5), 1317–1320 (1996).
  • Ito M , MatsunoK, SakumotoY, HirataK, YukiN. Ataxic Guillain–Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J. Neurol. Neurosurg. Psychiatry82(3), 294–299 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.